sciencechemistryhealth

Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use

Clinical Chemistry Podcast·Nov 5, 2025·9:55·pending

About this Episode

Ruben Y Luo, Priscilla S W Yeung, Morgan W Mann, Lichao Zhang, Yifei K Yang, Andrew N Hoofnagle, Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use, Clinical Chemistry, Volume 71, Issue 11, November 2025, Pages 1111–1124, https://doi.org/10.1093/clinchem/hvaf094

Hosts & Guests

Association for Diagnostics

Host

Laboratory Medicine

Host

Yifei K Yang

Host

Andrew N Hoofnagle

Host

Priscilla S W Yeung

Host

Morgan W Mann

Host

Ruben Y Luo

Host

Lichao Zhang

Host

No transcript available for this episode.

Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use

About this Episode

Hosts & Guests

More from Clinical Chemistry Podcast

Audio Summary April 2026

PREEMPT'ing Overreliance on Peripheral Blood-Based ColoRectal Cancer Screening

A Turning Point for Lipoprotein(a) Treatment: Are Clinical Laboratories Ready?

Audio Summary March 2026